Advertisement

Artificial Intelligence


Tempus AI has agreed to acquire the cancer genomics company Personalis in a deal valued at about $1.5 billion, the companies announced July 20. The acquisition builds on a partnership the two companies formed in November 2023, when Tempus invested…

OpenEvidence has considered raising $200 million at a $20 billion valuation but is unlikely to move forward with the round, The Information reported July 17. A source involved in the discussions told the news outlet the deal would dilute shares…

When an AI vendor walks into Mass General Brigham with a bold ROI claim, the conversation doesn’t start with a pilot proposal. It starts with a form. Rebecca Mishuris, MD, chief health information officer at Somerville, Mass.-based Mass General Brigham,…

AI chiefs have become increasingly present in health systems, shaping governance, implementation and oversight. Health plans and their subsidiaries have been getting on the bandwagon, too.  While analytics- and technology-centric executives are often responsible for AI initiatives at companies, some…

Stanford University School of Medicine and Harvard Medical School researchers ranked 24 AI systems by clinical safety in a new benchmark study, finding four medical-specialized tools topped the list in a statistical tie. The findings come from NOHARM (Numerous Options…

More than 85% of Epic’s customers are now using its AI tools, and independent data from KLAS Research show clinicians who use them report a notably better EHR experience than those who don’t, though a training gap appears to be…

Microsoft CEO Satya Nadella criticized restrictions on Anthropic’s Claude Fable 5 model during an internal meeting with engineers working on Microsoft’s Copilot products, CNBC reported July 16. Mr. Nadella described the model as “so editorially controlled” and said its restrictions…

Advertisement

Most Read

Advertisement
Advertisement